|
Ms. Laudicina has served as our Vice President of Regulatory Affairs and Quality Assurance since September 2007. Prior to joining Cadence, Ms. Laudicina served as Executive Director of Worldwide Regulatory Affairs and Safety and Risk Management Lead at Pfizer, Inc., a global pharmaceutical company, where she led the regulatory team responsible for the registration of Sutent ® (sunitinib malate), a drug approved by the U.S. Food and Drug Administration for the treatment of advanced kidney cancer and gastrointestinal stromal tumors. From 2001 to 2002, Ms. Laudicina was Director of Regulatory Affairs at Prometheus Laboratories, Inc., a specialty pharmaceutical company. From 1999 to 2001, she served as Director of Regulatory Affairs at Dura Pharmaceuticals, a specialty respiratory and pulmonary drug delivery company. From 1997 until 1999, Ms. Laudicina served as Assistant Director of Regulatory Affairs at Pfizer. Between 1992 and 1997, she served in clinical research and regulatory affairs roles at Schering-Plough Corporation, a global science-based healthcare company. Ms. Laudicina holds a B.S. in Chemistry from Pedro Henriquez Urena University, Santo Domingo, and a M.S. in Chemistry from West Virginia University. | 